Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.
The isolation of human induced pluripotent stem cells (iPSCs) offers a new strategy for modelling human disease. Recent studies have reported the derivation and differentiation of disease-specific human iPSCs. However, a key challenge in the field is the demonstration of disease-related phenotypes and the ability to model pathogenesis and treatment of disease in iPSCs. Familial dysautonomia (FD) is a rare but fatal peripheral neuropathy, caused by a point mutation in the IKBKAP gene involved in transcriptional elongation. The disease is characterized by the depletion of autonomic and sensory neurons. The specificity to the peripheral nervous system and the mechanism of neuron loss in FD are poorly understood owing to the lack of an appropriate model system. Here we report the derivation of patient-specific FD-iPSCs and the directed differentiation into cells of all three germ layers including peripheral neurons. Gene expression analysis in purified FD-iPSC-derived lineages demonstrates tissue-specific mis-splicing of IKBKAP in vitro. Patient-specific neural crest precursors express particularly low levels of normal IKBKAP transcript, suggesting a mechanism for disease specificity. FD pathogenesis is further characterized by transcriptome analysis and cell-based assays revealing marked defects in neurogenic differentiation and migration behaviour. Furthermore, we use FD-iPSCs for validating the potency of candidate drugs in reversing aberrant splicing and ameliorating neuronal differentiation and migration. Our study illustrates the promise of iPSC technology for gaining new insights into human disease pathogenesis and treatment.
Lee
Gabsang
G
Developmental Biology Program, Sloan-Kettering Institute, 1275 York Ave, USA.
Papapetrou
Eirini P
EP
Kim
Hyesoo
H
Chambers
Stuart M
SM
Tomishima
Mark J
MJ
Fasano
Christopher A
CA
Ganat
Yosif M
YM
Menon
Jayanthi
J
Shimizu
Fumiko
F
Viale
Agnes
A
Tabar
Viviane
V
Sadelain
Michel
M
Studer
Lorenz
L
D000293:Adolescent; D017398:Alternative Splicing / Q000187:drug effects / Q000235:genetics; D000818:Animals; D002352:Carrier Proteins / Q000235:genetics; D054337:Cell Dedifferentiation; D002454:Cell Differentiation; D019070:Cell Lineage; D002465:Cell Movement; D002478:Cells, Cultured; D002648:Child; D004402:Dysautonomia, Familial / Q000188:drug therapy / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D020869:Gene Expression Profiling; D006801:Humans; D007701:Kinetin / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008954:Models, Biological; D009432:Neural Crest / Q000166:cytology / Q000187:drug effects; D009928:Organ Specificity; D010641:Phenotype; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism* / Q000637:transplantation*; D035602:Transcriptional Elongation Factors
D002352:Carrier Proteins; C114720:Elp1 protein, human; D035602:Transcriptional Elongation Factors; D007701:Kinetin
Nat Biotechnol. 2009 Mar;27(3):275-80
19252484
Biochem Biophys Res Commun. 2003 Jun 20;306(1):303-9
12788105
Biochem Biophys Res Commun. 2003 Oct 17;310(2):627-33
14521957
Nature. 2008 Jan 10;451(7175):141-6
18157115
Hum Mol Genet. 2004 Feb 15;13(4):429-36
14709595
Mol Cell. 2006 May 19;22(4):521-31
16713582
Science. 2008 Aug 29;321(5893):1218-21
18669821
Mol Cells. 2008 Jun 30;25(4):487-93
18511880
Nat Biotechnol. 2007 Dec;25(12):1468-75
18037878
Cell. 2009 Mar 6;136(5):964-77
19269371
Nat Biotechnol. 2005 Dec;23(12):1534-41
16258519
Neuron. 1995 Dec;15(6):1245-58
8845150
J Pediatr. 2002 Oct;141(4):518-23
12378191
Cell. 2008 Sep 5;134(5):877-86
18691744
Am J Hum Genet. 2001 Mar;68(3):753-8
11179021
Nature. 2009 Jan 15;457(7227):277-80
19098894
Expert Opin Pharmacother. 2005 Apr;6(4):561-7
15934882
Stem Cells. 2009 Mar;27(3):521-32
19074416
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12543-8
15310843
Nat Med. 2008 Feb;14(2):125-33
18246078
Am J Hum Genet. 2001 Mar;68(3):598-605
11179008
Nat Methods. 2007 Jun;4(6):501-9
17486087
Cell. 2007 Nov 30;131(5):861-72
18035408
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12759-64
19549847
Science. 2003 Aug 15;301(5635):972-6
12920301
Science. 2007 Dec 21;318(5858):1917-20
18029452
Blood. 2007 Apr 1;109(7):2679-87
17148580
J Cell Sci. 2008 Mar 15;121(Pt 6):854-64
18303054
Genes Dev. 2008 Jan 15;22(2):152-65
18198334